SeqLL Inc
OTC:ATLN

Watchlist Manager
SeqLL Inc Logo
SeqLL Inc
OTC:ATLN
Watchlist
Price: 3.75 USD 4.75% Market Closed
Market Cap: $219.5m

Operating Margin

-7.3%
Current
Improving
by 2 300.7%
vs 3-y average of -2 308%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-7.3%
=
Operating Income
$-32.7m
/
Revenue
$445.4m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-7.3%
=
Operating Income
$-32.7m
/
Revenue
$445.4m

Peer Comparison

Country Company Market Cap Operating
Margin
US
SeqLL Inc
OTC:ATLN
208.9m USD
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
236.9B USD
Loading...
US
Danaher Corp
NYSE:DHR
165.5B USD
Loading...
CH
Lonza Group AG
SIX:LONN
37.6B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.1B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
279.2B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
38.2B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.8B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.3B EUR
Loading...

Market Distribution

Lower than 71% of companies in the United States of America
Percentile
29th
Based on 14 112 companies
29th percentile
-7.3%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

SeqLL Inc
Glance View

SeqLL, Inc. engages in the design, development, and manufacture of genetic analysis technologies. The company is headquartered in Woburn, Massachusetts and currently employs 7 full-time employees. The company went IPO on 2021-08-27. The company offers ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) sequencing solutions. The company uses its true single molecule sequencing (tSMS) technology. SeqLL offers RNA and specialty DNA sequencing services utilizing tSMS. SeqLL offers a range of RNA sequencing services, including its direct RNA sequencing without conversion to complementary DNA (cDNA). The firm operates in a single business segment that includes the design, development and manufacturing of genetic analysis technologies. Its testing services are fully customizable to customers research needs and challenges. Its SeqLL technology is used for various application, such as life sciences research and development, liquid biopsy, clinical diagnostics and microbiome analysis. The tSMS platform offers a sample preparation process.

ATLN Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-7.3%
=
Operating Income
$-32.7m
/
Revenue
$445.4m
What is SeqLL Inc's current Operating Margin?

The current Operating Margin for SeqLL Inc is -7.3%, which is above its 3-year median of -2 308%.

How has Operating Margin changed over time?

Over the last 3 years, SeqLL Inc’s Operating Margin has increased from -3 630.2% to -7.3%. During this period, it reached a low of -15 650.3% on Mar 31, 2023 and a high of -4.9% on Dec 31, 2024.

Back to Top